OPKO Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OPKO Health, Inc. on December 5, 2007, reporting events occurring on December 4, 2007. The filing details a material definitive agreement involving a private investment in the Company's common stock.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or debt levels. The primary financial data disclosed relates to a specific capital transaction:
- Investment Amount: $20 million
- Shares Issued: 10,869,565 shares of common stock
- Price Per Share: $1.84
- Discount to Market: Approximately 40% below the five-day average trading price on the American Stock Exchange
Material Changes
The most significant change reported is the increase in beneficial ownership by The Frost Group. Following this investment, members of The Frost Group (controlled by Chairman and CEO Dr. Phillip Frost) will collectively own approximately 62% of OPKO's outstanding common stock. The transaction was executed as a private placement exempt from registration under Section 4(2) of the Securities Act of 1933.
Outlook, Risks, and Unusual Items
Restrictions: The shares issued in this transaction are restricted securities subject to a two-year lock-up period. No registration rights were granted to the investors.
Investor Composition: The Frost Group includes key Company executives: Dr. Jane Hsiao (Vice Chairman and CTO), Dr. Rao Uppaluri (CFO), and Mr. Steven D. Rubin (Executive Vice President-Administration).
Management Commentary: The filing incorporates a press release dated December 5, 2007, but does not contain forward-looking guidance or specific risk factors beyond the standard disclosure of the private nature of the offering.
Key Facts for Investor Verification
- Verify the current trading price of OPKO stock to confirm the 40% discount calculation relative to the five-day average at the time of the transaction.
- Confirm the total number of outstanding shares post-transaction to validate the 62% beneficial ownership figure for The Frost Group.
- Review the two-year lock-up agreement terms to understand potential future selling pressure or lack thereof.
- Check subsequent filings for any updates on the utilization of the $20 million capital raised.